Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia
Public ClinicalTrials.gov record NCT03121586. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 52-Week, Open-Label, Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the long-term safety and tolerability of pimavanserin after 52 weeks of adjunctive treatment in subjects with schizophrenia
Study identification
- NCT ID
- NCT03121586
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 995 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2017 (Actual)
- Primary completion
- Apr 30, 2024 (Actual)
- Completion
- May 30, 2024 (Actual)
- Last update posted
- Aug 24, 2025
2017 – 2024
United States locations
- U.S. sites
- 32
- U.S. states
- 16
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 171-Alea Research Institute | Phoenix | Arizona | 85012 | — |
| 156-Woodland International Research Group, LLC | Little Rock | Arkansas | 72211 | — |
| 111-Woodland Research Northwest, LLC | Rogers | Arkansas | 72758 | — |
| 167-CITrials - Bellflower | Bellflower | California | 90706 | — |
| 105-ProScience Research Group | Culver City | California | 90230 | — |
| 123-Synergy San Diego | Lemon Grove | California | 91945 | — |
| 164-Artemis Institute for Clinical Research | San Diego | California | 92103 | — |
| 165-CITrials | Santa Ana | California | 92705 | — |
| 108-Collaborative Nueroscience Network, LLC | Torrance | California | 90502 | — |
| 125-Galiz Research | Hialeah | Florida | 33016 | — |
| 137-Innovative Clinical Research, Inc. | Lauderhill | Florida | 33319 | — |
| 146-Premier Clinical Research Institute, Inc. | Miami | Florida | 33122 | — |
| 162-Synexus Clinical Research, Inc. | Atlanta | Georgia | 30328 | — |
| 168-Atlanta Center for Medical Research | Atlanta | Georgia | 30331 | — |
| 102-Northwest Behavioral Research Center | Marietta | Georgia | 30060 | — |
| 114-Northwestern University | Chicago | Illinois | 60611 | — |
| 101-American Medical Research | Chicago | Illinois | 60612 | — |
| 130-Alexian Brothers Center for Psychiatric Research | Hoffman Estates | Illinois | 60169 | — |
| 118-Lake Charles Clinical Trials | Lake Charles | Louisiana | 70629 | — |
| 124-Altea Research Institute | Las Vegas | Nevada | 89102 | — |
| 141-Hassman Research Institute | Berlin | New Jersey | 08009 | — |
| 153-Albuquerque Neuroscience Inc. | Albuquerque | New Mexico | 87109 | — |
| 104-Neurobehavioral Research, Inc. | Cedarhurst | New York | 11516 | — |
| 140-Synexus Clinical Research, Inc - 140 | Jamaica | New York | 11432 | — |
| 128-Finger Lakes Clinical Research | Rochester | New York | 14618 | — |
| 106-New Hope Clinical Research | Charlotte | North Carolina | 28211 | — |
| 145-Carolina Behavioral Care | Durham | North Carolina | 27704 | — |
| 110-Cutting Edge Research Group | Oklahoma City | Oklahoma | 73116 | — |
| 170-Suburban Research Associates | Downingtown | Pennsylvania | 19335 | — |
| 127-University Hills Clinical Research | Irving | Texas | 75062 | — |
| 103-Pillar Clinical Research, LLC | Richardson | Texas | 75080 | — |
| 115-Psychiatric and Behavioral Solutions LLC | Salt Lake City | Utah | 84105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 129 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03121586, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 24, 2025 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03121586 live on ClinicalTrials.gov.